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The Hormone Response Element Mimic Sequence of GAS5 LncRNA is 
Sufficient to Induce Apoptosis in Breast Cancer Cell Lines 
MR Pickard & GT Williams 
Keele University, UK. 
 
Growth arrest-specific 5 (GAS5) encodes snoRNAs and lncRNA. The latter promotes 
apoptosis, but its expression is down-regulated in breast cancer. The mTOR and 
nonsense-mediated decay pathways together regulate GAS5 transcript levels but 
rapalogues fail to enhance GAS5 levels in triple-negative breast cancer cells, so that 
mTOR inhibitor-independent induction of GAS5 may be more productive in 
enhancing apoptotic responses to therapies in breast cancer. Notably, GAS5 lncRNA 
acts by riborepression of glucocorticoid/related receptors; a stem-loop sequence 
constitutes the GAS5 hormone response element mimic (HREM).  The aim of this 
study was to determine if the GAS5 HREM sequence alone is sufficient to promote 
the apoptosis of breast cancer cells. 
Cells were nucleofected with a DNA oligonucleotide corresponding to the GAS5 
lncRNA HREM; controls received oligonucleotides either with scrambled GAS5 
sequence or with stem complementarity present but lacking the GAS5 HRE 
consensus. Cells were irradiated with ultraviolet-C (UV-C) light at 20 h post-
transfection to induce apoptosis.  
The basal apoptotic rate almost doubled in MCF7 and MDA-MB-231 cells 
transfected with the HREM oligonucleotide compared with controls. This effect was 
apparent at 20 h post-transfection, and a corresponding decrease was observed in 
culture viability; clonogenic activity was also impaired. The HREM sequence also 
enhanced UV-C-induced apoptosis in an additive manner in both cell lines. 
Endogenous GAS5 lncRNA expression was unaffected by transfection of the HREM 
sequence. Thus the GAS5 lncRNA HREM is sufficient to induce apoptosis in breast 
cancer cells, including TNBC cells and this may serve as the basis for the 
development of novel oligonucleotide cancer therapies. 
 
